Conde D - Search Results

1

Atrial fibrillation: an observational study with outpatients.

Albina G, De Luca J, Conde D, Giniger A. Albina G, et al. Among authors: conde d. Pacing Clin Electrophysiol. 2014 Nov;37(11):1485-91. doi: 10.1111/pace.12462. Epub 2014 Jul 16. Pacing Clin Electrophysiol. 2014. PMID: 25040946

2

Flecainide or propafenone vs. vernakalant for conversion of recent-onset atrial fibrillation.

Conde D, Costabel JP, Aragon M, Caro M, Ferro A, Klein A, Trivi M, Giniger A. Conde D, et al. Can J Cardiol. 2013 Oct;29(10):1330.e13. doi: 10.1016/j.cjca.2013.01.002. Epub 2013 Mar 5. Can J Cardiol. 2013. PMID: 23465347 No abstract available.

3

Flecainide versus vernakalant for conversion of recent-onset atrial fibrillation.

Conde D, Costabel JP, Caro M, Ferro A, Lambardi F, Corrales Barboza A, Lavalle Cobo A, Trivi M. Conde D, et al. Int J Cardiol. 2013 Oct 3;168(3):2423-5. doi: 10.1016/j.ijcard.2013.02.006. Epub 2013 Mar 19. Int J Cardiol. 2013. PMID: 23518212

4

Propafenone versus vernakalant for conversion of recent-onset atrial fibrillation.

Conde D, Costabel JP, Aragon M, Lambardi F, Klein A, Corrales Barbosa A, Trivi M, Giniger A. Conde D, et al. Cardiovasc Ther. 2013 Dec;31(6):377-80. doi: 10.1111/1755-5922.12036. Cardiovasc Ther. 2013. PMID: 23683253 Free article. Clinical Trial.

5

Conversion of recent onset atrial fibrillation: which drug is faster?

Conde D. Conde D. Am J Emerg Med. 2013 Sep;31(9):1410-1. doi: 10.1016/j.ajem.2013.05.039. Epub 2013 Jun 22. Am J Emerg Med. 2013. PMID: 23796978 No abstract available.

6

Vernakalant versus electrical cardioversion in recent-onset atrial fibrillation.

Conde D, Lalor N, Rodriguez L, Elissamburu P, Marcelo T. Conde D, et al. Int J Cardiol. 2013 Oct 9;168(4):4431-2. doi: 10.1016/j.ijcard.2013.06.055. Epub 2013 Jul 23. Int J Cardiol. 2013. PMID: 23890913 No abstract available.

7

Vernakalant: Perception of state of health in patients with a recent-onset atrial fibrillation.

Conde D, Costabel JP, Aragon M, Lambardi F, Trivi M. Conde D, et al. Cardiol J. 2014;21(3):304-8. doi: 10.5603/CJ.a2013.0113. Epub 2013 Aug 30. Cardiol J. 2014. PMID: 23990184

8

Is vernakalant better or not, compared with other treatments for conversion of acute atrial fibrillation?

Conde D. Conde D. Int J Cardiol. 2013 Oct 30;169(2):95-6. doi: 10.1016/j.ijcard.2013.08.139. Epub 2013 Sep 5. Int J Cardiol. 2013. PMID: 24071384

9

Advanced interatrial block is associated with recurrence of atrial fibrillation post pharmacological cardioversion.

Enriquez A, Conde D, Hopman W, Mondragon I, Chiale PA, de Luna AB, Baranchuk A. Enriquez A, et al. Among authors: conde d. Cardiovasc Ther. 2014 Apr;32(2):52-6. doi: 10.1111/1755-5922.12063. Cardiovasc Ther. 2014. PMID: 24417765 Free article.

10

Relation of interatrial block to new-onset atrial fibrillation in patients with Chagas cardiomyopathy and implantable cardioverter-defibrillators.

Enriquez A, Conde D, Femenia F, de Luna AB, Ribeiro A, Muratore C, Valentino M, Retyk E, Galizio N, Hopman WM, Baranchuk A. Enriquez A, et al. Among authors: conde d. Am J Cardiol. 2014 May 15;113(10):1740-3. doi: 10.1016/j.amjcard.2014.02.036. Epub 2014 Mar 2. Am J Cardiol. 2014. PMID: 24698463

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

263 results

Search Page

Filters